Microencapsulation of Leydig Cells: A System for Testosterone Supplementation

Endocrinology

Volumn 144, Issue 11, 2003, Pages 4975-4979

  Machluf, Marcelle ^a   Orsola, Anna ^a   Boorjian, Stephen ^a   Kershen, Richard ^a   Atala, Anthony ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; TESTOSTERONE;

ANIMAL CELL; ARTICLE; BONE MASS; CASTRATION; CONTROLLED STUDY; ERECTILE DYSFUNCTION; FLUID RETENTION; HORMONAL THERAPY; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HYPERTENSION; LEYDIG CELL; LIBIDO; MALE; MALE INFERTILITY; MICROENCAPSULATION; MUSCLE STRENGTH; NONHUMAN; PRIORITY JOURNAL; RAT; TESTOSTERONE BLOOD LEVEL;

ALGINATES; ANIMALS; BIOCOMPATIBLE MATERIALS; CELLS, CULTURED; DRUG DELIVERY SYSTEMS; LEYDIG CELLS; MALE; MICROSPHERES; ORCHIECTOMY; POLYLYSINE; RATS; RATS, SPRAGUE-DAWLEY; TESTOSTERONE;

EID: 0242468474     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-0411     Document Type: Article

References (17)

1. Bhasin S, Bremner WJ 1997 Clinical review 85: emerging issues in androgen replacement therapy. J Clin Endocrinol Metab 82:3-8
2. Cantrill JA, Dewis P, Large DM, Newman M, Anderson DC 1984 Which testosterone replacement therapy? Clin Endocrinol (Oxf) 21:97-107
3. Snyder PJ, Lawrence DA 1980 Treatment of male hypogonadism with testosterone enanthate. J Clin Endocrinol Metab 51:1335-1339
4. McClellan KJ, Goa KL 1998 Transdermal testosterone. Drugs 55:253-258; discussion 259
5. Santen RJ, Swerdloff RS, Clinical aspects of androgen therapy. Workshop Conference on Androgen Therapy: Biologic and Clinical Consequences, Penn State Workshop Proceedings, Philadelphia, PA, 1990, p 40
6. Tai J, Johnson HW, Tze WJ 1989 Successful transplantation of Leydig cells in castrated inbred rats. Transplantation 47:1087-1089
7. van Dam JH, Teerds KJ, Rommerts FF 1989 Transplantation and subsequent recovery of small amounts of isolated Leydig cells. Arch Androl 22:123-129
8. De Vos P, De Haan B, Van Schilfgaarde R 1997 Effect of the alginate composition on the biocompatibility of alginate-polylysine microcapsules. Biomaterials 18:273-278
9. Tai IT, Sun AM 1993 Microencapsulation of recombinant cells: a new delivery system for gene therapy. FASEB J 7:1061-1069
10. Lim F, Sun AM 1980 Microencapsulated islets as bioartificial endocrine pancreas. Science 210:908-910
11. Lanza RP, Hayes JL, Chick WL 1996 Encapsulated cell technology. Nat Biotechnol 14:1107-1111
12. Joki T, Machluf M, Atala A, Zhu J, Seyfried NT, Dunn IF, Abe T, Carroll RS, Black PM 2001 Continuous release of endostatin from microencapsulated engineered cells for tumor therapy. Nat Biotechnol 19:35-39
13. Schuch G, Machluf M, Bartsch Jr G, Nomi M, Richard H, Atala A, Soker S 2002 In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo. Blood 100:4622-4628
14. Lee MS, Hong SJ, Choi HR, Rha KH 1994 Testosterone productivity and histostructural changes of autotransplanted rat Leydig cells. Yonsei Med J 35:260-270
15. Machluf M, Regev O, Peled Y, Kost J, Cohen S 1997 Characterization of microencapsulated liposome systems for the controlled delivery of liposome-associated macromolecules. J Control Release 43:35-45
16. Sharpe RM, Maddocks S, Kerr JB 1990 Cell-cell interactions in the control of spermatogenesis as studied using Leydig cell destruction and testosterone replacement. Am J Anat 188:3-20
17. Kmicikiewicz I, Koziel E, Pelczar U, Pierscinski A, Bilinska B 1998 Mouse Leydig cell culture on microcarriers. Acta Histochem 100:297-307